MCF Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.6K Sell
506
-380
-43% -$34.7K ﹤0.01% 690
2026
Q1
$32.9K Buy
886
+249
+39% +$7.96K ﹤0.01% 698
2025
Q4
$12.9K Buy
637
+314
+97% +$7.59K ﹤0.01% 775
2025
Q3
$9.73K Buy
+323
New +$6.99K ﹤0.01% 702
2024
Q2
Sell
-203
Closed -$2.52K 1026
2024
Q1
$2.52K Hold
203
﹤0.01% 792
2023
Q4
$5.39K Sell
203
-162
-44% -$4.72K ﹤0.01% 670
2023
Q3
$16.7K Hold
365
﹤0.01% 510
2023
Q2
$15.1K Hold
365
﹤0.01% 512
2023
Q1
$11.3K Buy
+365
New +$11.8K ﹤0.01% 552

Other funds holding AEHR

MCF Advisors's AEHR Position: Q2 2026 in Review

MCF Advisors reduced its Aehr Test Systems (AEHR) stake by 43% in Q2 2026, selling an estimated $34.7K and leaving 506 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #690.

MCF Advisors first reported a position in AEHR in Q1 2023 and has held it in 9 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • MCF Advisors held 506 shares of Aehr Test Systems worth $48.6K as of Q2 2026.
  • MCF Advisors sold 380 Aehr Test Systems shares in Q2 2026, an estimated $34.7K.
  • Aehr Test Systems made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #690 holding.
  • MCF Advisors first reported a position in Aehr Test Systems in Q1 2023 and has held it in 9 quarters since.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.